David Shaw’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
David Shaw's AVXL Position: Q3 2026 in Review
David Shaw increased its Anavex Life Sciences (AVXL) stake by 66% in Q3 2026, buying an estimated $211K and bringing the position to 191,638 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #4380.
David Shaw first reported a position in AVXL in Q2 2016 and has held it in 24 quarters since. The position peaked at $3.81M in Q1 2022. 167 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- David Shaw held 191,638 shares of Anavex Life Sciences worth $387K as of Q3 2026.
- David Shaw bought 76,176 Anavex Life Sciences shares in Q3 2026, an estimated $211K.
- Anavex Life Sciences made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4380 holding.
- David Shaw first reported a position in Anavex Life Sciences in Q2 2016 and has held it in 24 quarters since.
- David Shaw's Anavex Life Sciences position peaked at $3.81M in Q1 2022.
- 167 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.